Research indicates that targeting PRKCI with miR-630 suppresses the activation of the Hedgehog signaling pathway, thereby impeding the self-renewal, proliferation, and tumorigenic potential of cancer stem cells while concurrently downregulating the expression of stem cell markers Oct4 and Nanog [52]. This evidence concerns the gene POU5F1 and cancer.